Medium-dose estrogen ameliorates experimental autoimmune encephalomyelitis in ovariectomized mice

Journal of Immunotoxicology

Volumn 13, Issue 6, 2016, Pages 885-896

  Haghmorad, Dariush ^a   Salehipour, Zohreh ^b   Nosratabadi, Reza ^c   Rastin, Maryam ^b   Kokhaei, Parviz ^a   Mahmoudi, Mohammad Bagher ^d   Amini, Abbas Ali ^e   Mahmoudi, Mahmoud ^b  

^a SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

central nervous system; EAE; Estrogen; multiple sclerosis; transcription factor

Indexed keywords

ESTROGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; DOWN REGULATION; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TREATMENT DURATION; ANIMAL; C57BL MOUSE; CELL CULTURE; DOSE CALCULATION; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; MULTIPLE SCLEROSIS; PREGNANCY; REGULATORY T LYMPHOCYTE; TH2 CELL;

ANIMALS; CELLS, CULTURED; CYTOKINES; DRUG DOSAGE CALCULATIONS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ESTROGENS; FEMALE; HUMANS; IMMUNE TOLERANCE; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; OVARIECTOMY; PREGNANCY; T-LYMPHOCYTES, REGULATORY; TH2 CELLS; TRANSCRIPTION FACTORS;

EID: 84986199815     PISSN: 1547691X     EISSN: 15476901     Source Type: Journal    
DOI: 10.1080/1547691X.2016.1223768     Document Type: Article

References (57)

1. + T-cells exacerbates experimental autoimmune encephalomyelitis induced by mouse, but not rat, antigens. J Neurosci Res. 87:3511–3519.
2. H2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis. J Neurol Sci. 222:21–27.
3. reg and T-effector cells in autoimmune CNS inflammation:A delicate balance, easily disturbed. Eur J Immunol. 40:3321–3324.
4. Bebo B, Dehghani B, Foster S, Kurniawan A, Lopez F, Sherman L., 2009. Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis. Glia. 57:777–790.
5. Berard J, Zarruk J, Arbor N, Prat A, Yong V, Jacques F, Akira S, David S., 2012. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia. 60:1145–1159.
6. Bodhankar S, Galipeau D, Vandenbark AA, Offner H., 2013. PD-1 interaction with PD-L1 but not PD-L2 on B-cells mediates protective effects of estrogen against EAE. J Clin Cell Immunol. 4:143.
7. Bodhankar S, Wang C, Vandenbark A, Offner H., 2011. Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B-cells. Eur J Immunol. 41:1165–1175.
8. Cala CM, Moseley CE, Steele C, Dowdy SM, Cutter GR, Ness JM, DeSilva TM. 2016. T cell cytokine signatures:Biomarkers in pediatric multiple sclerosis. J Neuroimmunol. 297:1–8.
9. Chen X, Shen Y, Liang Q, Flavell R, Hong Z, Yin Z, Wang M., 2014. Effect of bavachinin and its derivatives on T-cell differentiation. Int Immunopharmacol. 19:399–404.
10. Dai H, Ciric B, Zhang G, Rostami A., 2012. Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor. J Neuroimmunol. 245:1–7.
11. H17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol. 12:568–575.
12. + regulatory T-cells by intravenous immunoglobulin:A critical factor in controlling experimental autoimmune encephalomyelitis. Blood. 111:715–722.
13. H2-biased GATA3 transgenic mice. Intl J Mol Sci. 15:1700–1718.
14. Fletcher J, Lalor S, Sweeney C, Tubridy N, Mills K., 2010. T-cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol. 162:1–11.
15. Fontenot J, Dooley J, Farr A, Rudensky A., 2005. Developmental regulation of Foxp3 expression during ontogeny. J Exp Med. 202:901–906.
16. H2 cells. J Neuroimmunol. 277:85–95.
17. Haghmorad D, Mahmoudi M, Mahmoudi M, Rab S, Rastin M, Shegarfi H, Azizi G, Mirshafiey A., 2014b. Calcium intervention ameliorates experimental model of multiple sclerosis. Oman Med J. 29:185–189.
18. Harrirchian MH, Honarvar NM, Koohdani F, Bitarafan S, Siassi F, Jafarirad S, Abdolahi M, Salehi E, Saharian MA, Rouystaee H, et al. 2014. The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients:study protocol for a randomized controlled trial. Acta Med Iranica. 52:94.
19. H17 responses to myelin basic protein and disease activity in multiple sclerosis. Immunology. 125:161–169.
20. Horstmann L, Schmid H, Heinen AP, Kurschus F, Dick H, Joachim S., 2013. Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model. J Neuroinflammation. 10:120.
21. Huehnchen P, Prozorovski T, Klaissle P, Lesemann A, Ingwersen J, Wolf S, Kupsch A, Aktas O, Steiner B., 2011. Modulation of adult hippocampal neurogenesis during myelin-directed autoimmune neuroinflammation. Glia. 59:132–142.
22. reg cells mediate recovery from EAE by controlling effector T cell proliferation and motility in the CNS. Acta Neuropathol Commun. 2:163.
23. Kroenke M, Carlson T, Andjelkovic A, Segal B., 2008. IL-12- and IL-23-modulated T-cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med. 205:1535–1541.
24. reg cells in a mouse model of systemic lupus erythematosus. Immunopharmacol Immunotoxicol. 37:12–18.
25. + T-cells as candidates for regenerative therapies in a mouse model of multiple sclerosis. Berlin:Freie Universität.
26. Liston A, Gray D., 2014. Homeostatic control of regulatory T-cell diversity. Nat Rev Immunol. 14:154–165.
27. Liu R, Wen Y, Perez E, Wang X, Day A, Simpkins J, Yang S., 2005. 17β-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res. 1060:55–61.
28. H17:Are T cell cytokines relevant in multiple sclerosis? Biochim Biophys Acta. 1812:246–251.
29. Markoullis K, Sargiannidou I, Gardner C, Hadjisavvas A, Reynolds R, Kleopa K., 2012. Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis. Glia. 60:1053–1066.
30. Markovic-Plese S, McFarland H., 2001. Immunopathogenesis of the multiple sclerosis lesion. Curr Neurol Neurosci Rep. 1:257–262.
31. H3 immune-deviation. J Neuroimmunol. 92:113–121.
32. Miller S, Karpus W., 2007. Experimental autoimmune encephalomyelitis in the mouse. Curr Protoc Immunol. Chapter Unit-15.1.
33. Milo R, Kahana E., 2010. Multiple sclerosis:Geoepidemiology, genetics and the environment. Autoimmun Rev. 9:A387–A394.
34. Mosayebi G, Haghmorad D, Namaki S, Ghazavi A, Ekhtiari P, Mirshafiey A., 2010. Therapeutic effect of EDTA in experimental model of multiple sclerosis. Immunopharmacol Immunotoxicol. 32:321–326.
35. H17 cells and up-regulating regulatory T-cells. Nanomedicine. 12:1961–1971.
36. Nosratabadi R, Rastin M, Sankian M, Haghmorad D, Tabasi N, Zamani S, Aghaee A, Salehipour Z, Mahmoudi M., 2015. St. John’s Wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells. J Immunotoxicol. 13:364–374.
37. H2 cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab. BMC Neurol. 12:95.
38. Papenfuss T, Rogers C, Gienapp I, Yurrita M, McClain M, Damico N, Valo J, Song F, Whitacre C., 2004. Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J Neuroimmunol. 150:59–69.
39. Park H, Li Z, Yang X, Chang S, Nurieva R, Wang Y, Wang Y, Hood L, Zhu Z, Tian Q, et al. 2005. A distinct lineage of CD4 T-cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 6:1133–1141.
40. Pelfrey C, Rudick R, Cotleur A, Lee J, Tary-Lehmann M, Lehmann P., 2000. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production. J Immunol. 165:1641–1651.
41. reg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int Immunol. 19:337–343.
42. Polanczyk M, Jones R, Subramanian S, Afentoulis M, Rich C, Zakroczymski M, Cooke P, Vandenbark AA, Offner H., 2004. T-lymphocytes do not directly mediate protective effect of estrogen on experimental autoimmune encephalomyelitis. Am J Pathol. 165:2069–2077.
43. Rastin M, Mahmoudi M, Hatef M, Sahebari M, Tabasi N, Haghmorad D, Nosratabadi R, Zamani S, Khazaee M, Masoudian M., 2013. T-lymphocyte apoptosis in systemic lupus erythematosus patients. Iran J Basic Med Sci. 16:936–941.
44. H17 cells in the pathogenesis of CNS inflammatory demyelination. J Neurol Sci. 333:76–87.
45. Shin J, Yang S, Jeong S, Park H, Choi Y, Park E., 2013. Activation of ER-β reduces blood-brain barrier breakdown following ischemic injury. Neuroscience. 235:165–173.
46. Sinha S, Kaler L, Proctor T, Teuscher C, Vandenbark A, Offner H., 2008. IL-13-mediated gender difference in susceptibility to autoimmune encephalomyelitis. J Immunol. 180:2679–2685.
47. Spence R, Hamby M, Umeda E, Itoh N, Du S, Wisdom A, Cao Y, Bondar G, Lam J, Ao Y, et al. 2011. Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci USA. 108:8867–8872.
48. Spence R, Voskuhl R., 2012. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front Neuroendocrinol. 33:105–115.
49. reg cells. Eur J Immunol. 39:1108–1117.
50. Wang C, Li Y, Proctor T, Vandenbark A, Offner H., 2010. Down-modulation of programmed death 1 alters regulatory T-cells and promotes experimental autoimmune encephalomyelitis. J Neurosci Res. 88:7–15.
51. regs. J Clin Invest. 116:2434–2441.
52. Whitacre C, Reingold S, O’Looney P., 1999. A gender gap in autoimmunity. Science. 283:1277–1278.
53. Yates M, Li Y, Chlebeck P, Offner H., 2010. GPR30, but not estrogen receptor-α, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol. BMC Immunol. 11:20.
54. Zhang X, Lund H, Mia S, Parsa R, Harris R., 2014. Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice. Glia. 62:804–817.
55. + T-cells. Curr Opin Immunol. 21:281–285.
56. Zhu B, Trikudanathan S, Zozulya A, Sandoval-Garcia C, Kennedy J, Atochina O, Norberg T, Castagner B, Seeberger P, Fabry Z, et al. 2011. Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis. Clin Immunol. 142:351–361.
57. Zozulya AL, Wiendl H., 2008. The role of regulatory T-cells in multiple sclerosis. Nat Clin Pract Neurol. 4:384–398.